[HTA Rapid report-Velexbru (primary CNS b-cell lymphoma)]
Center for Drug Evaluation
Record ID 32018013839
Chinese (Mandarin)
Details
Project Status:
Completed
Year Published:
2024
URL for published report:
https://www.cde.org.tw/media/b3uheb12/11302_10_%E8%A8%8E%E8%AB%96%E6%A1%88%E7%AC%AC8%E6%A1%88_velexbru.pdf?mediaDL=true
English language abstract:
There is no English language summary available
Publication Type:
Rapid Review
MeSH Terms
- Lymphoma
- Lymphoma, B-Cell
- Tyrosine Kinase Inhibitors
- Central Nervous System Neoplasms
- Immunosuppressive Agents
- Agammaglobulinaemia Tyrosine Kinase
Contact
Organisation Name:
Center for Drug Evaluation
Contact Address:
3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name:
Li Ying (Grace) Huang
Contact Email:
lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.